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Case Report
Unusual Presentation of Bilateral Adrenocortical Carcinoma 
Mimicking Adrenal Metastasis
Dong Gon Kim, Sang Deuk Kim, Jai Seong Cha, Chul-Ho Pak
1, Myung Ki Kim
Department of Urology, Chonbuk National University Medical School, Jeonju, 
1Chosun University College of Medicine, Gwangju, Korea
A 75-year-old female visited our hospital with bilateral adrenal masses that were de-
tected incidentally during lumbar spine magnetic resonance imaging (MRI) for the 
evaluation of radiating flank pain. Consecutive computed tomography and MRI re-
vealed bilateral adrenal masses with no evidence of lymph node enlargement or local 
invasion; 2[(18)F]fluoro-2-deoxyglucose (FDG)-positron emission tomography showed 
an intense FDG accumulation in both adrenal glands without abnormal FDG uptake 
in extra-adrenal regions. The laboratory test results were within normal ranges. We 
performed a bilateral adrenalectomy. The pathologic diagnosis of both adrenal masses 
was consistent with adrenocortical carcinoma. The patient recovered well with no 
complications.
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Primary malignant tumors originating from the adrenal 
gland include adrenocortical carcinomas, primary adrenal 
lymphomas, and malignant pheochromocytomas; how-
ever, the incidence of these tumors is low [1-4]. Most adre-
nal tumors are sporadic and unilateral, but 2% to 6% of 
adrenal tumors are bilateral and associated with Li-Fra-
umeni syndrome, type I multiple endocrine neoplasia, 
Beckwith-Wiedemann syndrome, and Carney complex, 
principally in children [1-4]. When bilateral adrenal mass-
es are detected, an effort is undertaken to find other pri-
mary malignant foci.
　There are a few reported cases of bilateral primary adre-
nocortical carcinomas [1]. Here we report one such case 
that was successfully managed with a bilateral adrenalec-
tomy and discuss the relevant literature.
CASE REPORT
A 75-year-old female was referred to our clinic with bi-
lateral adrenal masses that were detected incidentally by 
lumbar spine magnetic resonance imaging (MRI) for evalu-
ation of radiating flank pain. She presented with a high 
blood glucose level that had been controlled with medical 
treatment for 10 years. She had undergone surgery for a 
compressive fracture of the lumbar spine 3 months 
previously. A contrast-enhanced computer tomography 
(CT) scan was performed and revealed a left adrenal mass 
with inhomogeneous enhancement after application of 
contrast medium (40x18 mm) (Fig. 1A and 1B). On axial 
MRI, the bilateral adrenal masses had high-signal in-
tensity on T1- and T2-weighted images and a heteroge-
neous enhancement pattern (left, 48x19 mm; right, 29x23 
mm) (Fig. 1C and 1D). There was no evidence of lymph node 
enlargement or local invasion. For evaluation of other ma-
lignant lesion or metastases, a 2[(18)F]fluoro-2-deoxy-
glucose (FDG)-positron emission tomography (PET) scan 
was performed and showed an intense FDG accumulation 
in the bilateral adrenal masses without abnormal FDG up-
take in extra-adrenal regions (left, 38x20 mm; right, 35x28 
mm) (Fig. 2A). The results of adrenal function tests were 
within normal ranges. We performed a bilateral adrenalec-
tomy via a bilateral subcostal approach. The pathologic 
evaluation confirmed the diagnosis of adrenocortical 
carcinomas. The macroscopic findings were as follows: left 
adrenal tumor, 16x14 mm; and right adrenal tumor, 39x15 
mm. The adrenal masses reveal marked nuclear pleo-Korean J Urol 2011;52:715-717
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FIG. 1. Preoperative computed tomo-
graphy and axial magnetic resonance 
imaging. (A, B) Left adrenal tumor 
with inhomogeneous enhancement is 
shown. (C, D) Bilateral adrenal mas-
ses have heterogeneously high-signal 
intensity on both T1- and T2-weighted
images.
FIG. 2. Axial and sagittal positron 
emission tomography-computer tomo-
graphy scan. There was intense 
2[(18)F]fluoro-2-deoxyglucose (FDG) 
uptake in bilateral adrenal masses. 
There were no areas of abnormal FDG 
uptake. 
morphism with compact eosinophilic cytoplasm, numer-
ous mitoses, and necrosis. The adrenal masses were graded 
according to the Weiss criteria (0-9) with a score of 5 micro-
scopically (Fig. 3). The patient recovered well with no com-
plications at the 3-month follow-up.
DISCUSSION
Neoplastic involvement of the adrenal gland may result 
from primary tumors originating from the adrenal cortex 
of the adrenal medulla. Primary malignant tumors origi-
nating from the adrenal gland include adrenocortical carci-
nomas, primary adrenal lymphomas, and malignant 
pheochromocytomas. Adrenal glands are more frequently 
the site of metastatic disease caused by primary carci-
nomas. Any primary cancer can spread to the adrenal 
glands; lymphomas, lung cancer, melanomas, leukemia, 
renal carcinoma, and ovarian carcinoma account for the 
majority of adrenal metastases [1,4].
　The incidence of adrenocortical carcinoma is estimated 
to be 0.4/100,000. Adrenocortical carcinoma increases with 
tumor size to 25/100,000 (median diameter ＞6 cm) [4]. 
Bilateral manifestations of adrenocortical carcinoma oc-
cur in only 10% of the cases reported [1].
　In contrast to our patient, many patients with adreno-
cortical carcinomas present with clinical symptoms of en-Korean J Urol 2011;52:715-717
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FIG. 3. (A) Histopathologic findings of 
both adrenal masses. Marked nuclear 
pleomorphism with dense compact 
eosinophilic cytoplasms and numer-
ous mitoses (right; H&E, x400). (B) 
Marked nuclear pleomorphism with 
compact eosinophilic cytoplasms, nu-
merous mitoses, and necrosis (left; 
H&E, x400).
docrine excess. Indeed, hormone-functioning tumors ac-
count for 26% to 94% of adrenocortical carcinomas [3,4]. 
Most patients with adrenocortical carcinomas are diag-
nosed at an advanced stage of disease with large primary 
tumors (median tumor size at diagnosis, ＞10 cm) and in-
vasion to adjacent organs. The main clinical symptoms, 
such as abdominal discomfort or back pain, are related to 
the mass effect of a large tumor [3,4].
　All adrenal tumors detected have to be diagnosed for ma-
lignancy potential and hormonal activity to render timely 
and curative treatment. Imaging studies using CT, MRI, 
and FDG-PET to demonstrate adrenal mass size and ap-
pearance have been used to distinguish between benign 
and malignant lesions. Differentiation between malignant 
and benign adrenal lesions can be performed by using 
18-FDG-PET with ＞95% accuracy [4,5]. In particular, 
18-FDG-PET plays an important role in evaluating treat-
ment response and residual masses.
　In general, surgery involving adrenal tumors should be 
considered in patients with functioning cortical tumors 
and clinical symptoms [4,6,7]. Regarding nonfunctioning 
tumors, recommendations regarding treatment mainly re-
fer to the tumor size. In general, clinically silent lesions ＜3 
cm without any criteria of malignancy are not resected and 
should be followed closely by CT or MRI scans every 6 or 
12 months [4,6,7]. The indications for an adrenalectomy 
are a definitive or presumed diagnosis of primary adreno-
cortical carcinoma and circumstances technically ob-
structive to a minimally invasive approach. In the case of 
any intraoperative features of malignancy, conversion to 
an open approach should be performed to enable extensive 
radical compartment resection [3,6,7]. In our case, the in-
traoperative findings suggested a malignancy. Thus, we 
performed a bilateral adrenalectomy.
　The differentiation between benign and malignant adre-
nal lesions is based on macroscopic and microscopic fea-
tures [3,8]. The Weiss score is the most widely used classi-
fication for microscopic characteristics suggestive of a ma-
lignant tumor. Three or more histologic criteria are neces-
sary to establish the diagnosis of adrenal carcinoma [9]. In 
our case, marked nuclear atypia, frequent mitoses (8-10/10 
high power fields), vascular and capsular invasion, and ne-
crosis were found. Therefore, the diagnosis of primary bi-
lateral adrenocortical carcinoma was established.
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